Article thumbnail

Interaction Analysis between HLA-DRB1 Shared Epitope Alleles and MHC Class II Transactivator CIITA Gene with Regard to Risk of Rheumatoid Arthritis

By Marcus Ronninger, Maria Seddighzadeh, Morten Christoph Eike, Darren Plant, Nina A. Daha, Beate Skinningsrud, Jane Worthington, Tore K. Kvien, Rene E. M. Toes, Benedicte A. Lie, Lars Alfredsson and Leonid Padyukov

Abstract

HLA-DRB1 shared epitope (SE) alleles are the strongest genetic determinants for autoantibody positive rheumatoid arthritis (RA). One of the key regulators in expression of HLA class II receptors is MHC class II transactivator (CIITA). A variant of the CIITA gene has been found to associate with inflammatory diseases

Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:3312880
Provided by: PubMed Central

Suggested articles

Citations

  1. (2007). A candidate gene approach identifies the TRAF1/C5 region as a risk factor for rheumatoid arthritis.
  2. (1994). A comparison of the performance of different methods of disease classification for rheumatoid arthritis. Results of an analysis from a nationwide twin study.
  3. (2004). A geneenvironment interaction between smoking and shared epitope genes in HLADR provides a high risk of seropositive rheumatoid arthritis.
  4. (2004). A multicenter international evaluation of single-tube amplification protocols for sequencing-based typing of HLA-DRB1 and HLA-DRB3,4,5.
  5. (2006). A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination.
  6. (2005). Ahlbom A
  7. (2006). Calculating measures of biological interaction using R.
  8. (2012). CIITA gene variants are associated with rheumatoid arthritis in Scandinavian populations: an association study and meta-analysis. Manuscript submitted for publication.
  9. (2011). CIITA is not associated with risk of developing rheumatoid arthritis.
  10. (2010). CIITA variation in the presence of HLA-DRB1*1501 increases risk for multiple sclerosis.
  11. (1993). Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome).
  12. (2002). Epidemiology: an introduction.
  13. (2007). Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis.
  14. (2008). HLA DRDQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families.
  15. (2011). Interrogating the complex role of chromosome 16p13.13 in multiple sclerosis susceptibility: independent genetic signals in the CIITA-CLEC16A-SOCS1 gene complex.
  16. (2006). Investigation of the MHC2TA gene, associated with rheumatoid arthritis in a Swedish population, in a UK rheumatoid arthritis cohort.
  17. (2005). MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction.
  18. (2007). MHC2TA is associated with rheumatoid arthritis in Japanese patients.
  19. (2007). MHC2TA promoter polymorphism (2168*G/A, rs3087456) is not associated with susceptibility to rheumatoid arthritis in British Caucasian rheumatoid arthritis patients. Rheumatology (Oxford)
  20. (2008). Polymorphisms in CLEC16A and CIITA at 16p13 are associated with primary adrenal insufficiency.
  21. (2003). Prognostic factors for joint destruction in rheumatoid arthritis: a prospective longitudinal study of 318 patients.
  22. (2005). Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins.
  23. (2009). Rheumatoid arthritis.
  24. (2007). Role of the MHC2TA gene in autoimmune diseases.
  25. (2005). Silica exposure is associated with increased risk of developing rheumatoid arthritis: results from the Swedish EIRA study.
  26. (2005). Single nucleotide polymorphisms in the gene encoding the major histocompatibility complex class II transactivator (CIITA) in systemic lupus erythematosus.
  27. (2011). Smoking, citrullination and genetic variability in the immunopathogenesis of rheumatoid arthritis.
  28. (2006). Study of the role of a functional polymorphism of MHC2TA in rheumatoid arthritis in three ethnically different populations. Rheumatology (Oxford)
  29. (1988). The American Rheumatism Association
  30. (2001). The bare lymphocyte syndrome and the regulation of MHC expression.
  31. (2009). The influence of class II transactivator and interleukin-6 polymorphisms on the production of antibodies to donor human leucocyte antigen mismatches in renal allograft recipients.
  32. (2008). The MHC2TA -168A/G polymorphism and risk for rheumatoid arthritis: a meta-analysis of 6861 patients and 9270 controls reveals no evidence for association.
  33. (2003). The Oslo experience with arthritis registries.
  34. (1987). The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.